Annual Net Income
-$12.54 M
+$19.07 M+60.32%
31 December 2023
Summary:
Salarius Pharmaceuticals annual net profit is currently -$12.54 million, with the most recent change of +$19.07 million (+60.32%) on 31 December 2023. During the last 3 years, it has fallen by -$5.19 million (-70.60%). SLRX annual net income is now -80.83% below its all-time high of -$6.94 million, reached on 31 December 2019.SLRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$972.10 K
+$452.30 K+31.75%
30 September 2024
Summary:
Salarius Pharmaceuticals quarterly net profit is currently -$972.10 thousand, with the most recent change of +$452.30 thousand (+31.75%) on 30 September 2024. Over the past year, it has increased by +$1.47 million (+60.21%). SLRX quarterly net income is now -10.24% below its all-time high of -$881.80 thousand, reached on 31 December 2023.SLRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$4.99 M
+$1.47 M+22.75%
30 September 2024
Summary:
Salarius Pharmaceuticals TTM net profit is currently -$4.99 million, with the most recent change of +$1.47 million (+22.75%) on 30 September 2024. Over the past year, it has increased by +$13.04 million (+72.31%). SLRX TTM net income is now -128.05% below its all-time high of -$2.19 million, reached on 30 June 2014.SLRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLRX Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +60.3% | +60.2% | +72.3% |
3 y3 years | -70.6% | +74.0% | +52.1% |
5 y5 years | +42.8% | +63.0% | +35.7% |
SLRX Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -70.6% | +60.3% | -10.2% | +93.3% | at high | +84.2% |
5 y | 5 years | -80.8% | +60.3% | -10.2% | +93.3% | at high | +84.2% |
alltime | all time | -80.8% | +68.2% | -10.2% | +93.3% | -128.1% | +87.4% |
Salarius Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$972.10 K(-31.8%) | -$4.99 M(-22.8%) |
June 2024 | - | -$1.42 M(-17.0%) | -$6.46 M(-27.5%) |
Mar 2024 | - | -$1.72 M(+94.5%) | -$8.92 M(-28.9%) |
Dec 2023 | -$12.54 M(-60.3%) | -$881.80 K(-63.9%) | -$12.54 M(-30.4%) |
Sept 2023 | - | -$2.44 M(-37.0%) | -$18.03 M(-39.9%) |
June 2023 | - | -$3.88 M(-27.4%) | -$30.00 M(-2.7%) |
Mar 2023 | - | -$5.34 M(-16.2%) | -$30.84 M(-2.4%) |
Dec 2022 | -$31.61 M(+147.6%) | -$6.37 M(-55.8%) | -$31.61 M(+7.7%) |
Sept 2022 | - | -$14.41 M(+205.4%) | -$29.34 M(+57.2%) |
June 2022 | - | -$4.72 M(-22.8%) | -$18.67 M(+9.7%) |
Mar 2022 | - | -$6.11 M(+48.8%) | -$17.03 M(+33.3%) |
Dec 2021 | -$12.77 M(+73.7%) | -$4.10 M(+9.8%) | -$12.77 M(+22.4%) |
Sept 2021 | - | -$3.74 M(+21.6%) | -$10.43 M(+24.0%) |
June 2021 | - | -$3.07 M(+66.0%) | -$8.41 M(+18.1%) |
Mar 2021 | - | -$1.85 M(+4.8%) | -$7.12 M(-3.2%) |
Dec 2020 | -$7.35 M(+6.0%) | -$1.77 M(+3.0%) | -$7.35 M(-1.5%) |
Sept 2020 | - | -$1.72 M(-3.8%) | -$7.47 M(-10.9%) |
June 2020 | - | -$1.78 M(-14.4%) | -$8.38 M(+11.7%) |
Mar 2020 | - | -$2.08 M(+10.7%) | -$7.50 M(-1.9%) |
Dec 2019 | -$6.94 M | -$1.88 M(-28.3%) | -$7.64 M(-1.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2019 | - | -$2.63 M(+190.8%) | -$7.77 M(-0.1%) |
June 2019 | - | -$903.60 K(-59.5%) | -$7.78 M(-51.2%) |
Mar 2019 | - | -$2.23 M(+11.0%) | -$15.93 M(-27.3%) |
Dec 2018 | -$21.92 M(-36.3%) | -$2.01 M(-23.9%) | -$21.92 M(-21.5%) |
Sept 2018 | - | -$2.64 M(-70.9%) | -$27.94 M(-19.3%) |
June 2018 | - | -$9.05 M(+10.1%) | -$34.64 M(+0.7%) |
Mar 2018 | - | -$8.22 M(+2.4%) | -$34.39 M(-0.1%) |
Dec 2017 | -$34.43 M(-12.8%) | -$8.03 M(-14.0%) | -$34.43 M(+0.4%) |
Sept 2017 | - | -$9.33 M(+6.0%) | -$34.31 M(-3.7%) |
June 2017 | - | -$8.80 M(+6.5%) | -$35.61 M(-6.7%) |
Mar 2017 | - | -$8.27 M(+4.7%) | -$38.17 M(-3.4%) |
Dec 2016 | -$39.49 M(+35.5%) | -$7.90 M(-25.7%) | -$39.49 M(+0.0%) |
Sept 2016 | - | -$10.64 M(-6.4%) | -$39.49 M(+6.7%) |
June 2016 | - | -$11.36 M(+18.5%) | -$37.00 M(+13.1%) |
Mar 2016 | - | -$9.59 M(+21.5%) | -$32.72 M(+12.3%) |
Dec 2015 | -$29.14 M | -$7.89 M(-3.2%) | -$29.14 M(+37.1%) |
Sept 2015 | - | -$8.15 M(+15.2%) | -$21.25 M(+40.9%) |
June 2015 | - | -$7.08 M(+17.6%) | -$15.08 M(+48.0%) |
Mar 2015 | - | -$6.02 M(+202.9%) | -$10.19 M(+144.1%) |
Sept 2014 | - | -$1.99 M(-9.3%) | -$4.18 M(+90.7%) |
June 2014 | - | -$2.19 M | -$2.19 M |
FAQ
- What is Salarius Pharmaceuticals annual net profit?
- What is the all time high annual net income for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual net income year-on-year change?
- What is Salarius Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly net income year-on-year change?
- What is Salarius Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals TTM net income year-on-year change?
What is Salarius Pharmaceuticals annual net profit?
The current annual net income of SLRX is -$12.54 M
What is the all time high annual net income for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual net profit is -$6.94 M
What is Salarius Pharmaceuticals annual net income year-on-year change?
Over the past year, SLRX annual net profit has changed by +$19.07 M (+60.32%)
What is Salarius Pharmaceuticals quarterly net profit?
The current quarterly net income of SLRX is -$972.10 K
What is the all time high quarterly net income for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly net profit is -$881.80 K
What is Salarius Pharmaceuticals quarterly net income year-on-year change?
Over the past year, SLRX quarterly net profit has changed by +$1.47 M (+60.21%)
What is Salarius Pharmaceuticals TTM net profit?
The current TTM net income of SLRX is -$4.99 M
What is the all time high TTM net income for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high TTM net profit is -$2.19 M
What is Salarius Pharmaceuticals TTM net income year-on-year change?
Over the past year, SLRX TTM net profit has changed by +$13.04 M (+72.31%)